Sunday, August 16, 2026
HomeIndustriesBiotechnology

Biotechnology

Candid Therapeutics Partners with WuXi Biologics on T-cell Engager

Candid Therapeutics, Inc, a clinical-stage biotechnology company focused on becoming the leader in advancing T-cell engagers for autoimmune and inflammatory diseases, announced an agreement...

BlossomHill Therapeutics Names Geoff Oxnard, M.D., CMO

BlossomHill Therapeutics, Inc., a clinical-stage biotechnology company focused on the design and development of small molecule medicines for treating cancer and autoimmune diseases, announced...

General Proximity Raises $16M to Tackle ‘Undruggable’ Targets with Next-Gen Medicines

General Proximity, a breakthrough biotech platform company, announced its emergence from stealth, unveiling its proprietary OmniTAC platform designed to pioneer the next generation of...

Read Magazine’s Weekly News Roundup With Raytheon, eGrowcery, Roche, Dow , And More!

Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...

Sanofi Launches Phase 3 for PCV21, Expands SK Bioscience Partnership

Sanofi and SK bioscience have entered into a new chapter of their collaboration in pneumococcal vaccines with an expanded agreement to develop, license and...

Hot Topics